意大利罗马消息:据第25届国际眼科会议上报告的两项初步临床试验结果称,环孢素A可能是治疗Behcet氏病中慢性葡萄膜炎传统疗法以外的另一有效药物。美贝塞斯达国立眼科研究所Laure Cas-pers-Velu说,单独使用或与皮质类固醇联合使用时,这种免疫抑制剂很快改善了4名病人的病情,他们过去联合应用秋水仙碱、瘤可宁和环磷酰胺的传统疗法无效。 Behcet氏病被认为是一种自身免疫疾病,当此病在高峰状态时,产生典型的三联症:口疮性口炎、生殖器溃疡和可引起失明的眼炎。 Rome, Italy: According to two preliminary clinical trials reported at the 25th International Eye Conference, cyclosporin A may be another effective alternative to traditional therapies for chronic uveitis in Behcet’s disease. Laure Cas-pers-Velu, director of the National Eye Institute at Bethesda, Massachusetts, said the immunosuppressant quickly improved the condition of four patients when used alone or in combination with corticosteroids. In the past they used colchicine, Tumor Ning and cyclophosphamide traditional therapy is invalid. Behcet’s disease is thought to be an autoimmune disease that produces typical triad symptoms at the peak: aphthous stomatitis, genital ulcers, and ophthalmia causing blindness.